Insulin Derived From Plants On Human Trials

In todays world, with increasing number of insulin dependent diabetics, it is essential to identify an alternative sources to obtain insulin for treatment.

For the first time, scientists have injected humans with insulin grown in plants, in order to test if plants could provide cheaper source of insulin for diabetics.

Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.

Sembiosys Genetics, a Canadian company based in Calgary, Alberta, inserted human insulin genes into safflowers, causing them to make a compound called pro-insulin.

Enzymes acted upon pro-insulin and converted it into a type of insulin called SBS-1000.

Previous tests revealed that SBS-1000 is similar to human insulin, reports New Scientist.

Human Clinical Data on Oral Insulin Presented by Biocon in Rome
Bangalore, Sept 8 (ANI/Business Wire India): Biocon Limited, India's premier biotechnology company, announced the results of an ascending dose study with their oral insulin drug (IN-105)

Thus, last month Sembiosys went on to compare its effects with insulin from other sources in healthy volunteers.

Now, the company is planning to release the results later this year.

New Hope for Diabetics Via Insulin-producing Cells from Human Skin
In a groundbreaking achievement, scientists at the University of North Carolina at Chapel Hill School of Medicine have successfully transformed human skin cells into cells that produce

While majority of insulin products come from bacteria in a fermenter, which turns out to be an expensive process.

Therefore, Sembiosys is hoping that using plants could be cheaper, as they do not need this stage.

Genetically Engineered Cells in Pancreatic Cell Transplants Could Do Away With Daily Insulin Dose
Genetically engineered cells in pancreatic cell transplants could do away with daily insulin dose.

Safflowers are not widely grown in North America, and have no wild relatives there.

Thus, there's least risk of genes escaping from insulin-producing safflowers grown there, said Maurice Maloney of Sembiosys.

Source-ANI
PRI/SK